IMU 4.00% 4.8¢ imugene limited

Ann: Imugene Corporate Presentation, page-33

  1. 237 Posts.
    lightbulb Created with Sketch. 1106
    Given that this is a July presentation it appears that IMU needs to update the graphic on Slide 31 to align with the recent June 24th announcement

    Imugene Phase 1 onCARlytics trial doses first patient in Intravenous (IV) combination arm


    upload_2024-7-4_16-36-58.png

    GLTAH - Go Team Imugene
    .
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.